Atezolizumab Plus Chemo Misses Mark in TNBC ...Middle East

Medscape - News
The addition of atezolizumab to neoadjuvant chemotherapy failed to significantly improve event-free survival in patients with stages II-III triple-negative breast cancer. Medscape Medical News

Hence then, the article about atezolizumab plus chemo misses mark in tnbc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Atezolizumab Plus Chemo Misses Mark in TNBC )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News